Bsw Wealth Partners Eli Lilly & CO Transaction History

Bsw Wealth Partners

$606 Million
Q2 2024

A detailed history of Bsw Wealth Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Bsw Wealth Partners holds 3,102 shares of LLY stock, worth $2.75 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

3,102

Previous 3,078 0.78%

Holding current value

$2.75 Million

Previous $2.39 Million 17.29%

% of portfolio

0.46%

Previous 0.41%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$724.87 - $909.04 $17,396 - $21,816	24 Added 0.78%	3,102 $2.81 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $53,890 - $72,097	-91 Reduced 2.87%	3,078 $2.39 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $1,050 - $1,238	2 Added 0.06%	3,169 $1.85 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $161,273 - $222,340	371 Added 13.27%	3,167 $1.7 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $14,029 - $18,759	40 Added 1.45%	2,796 $1.31 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $4,348 - $5,107	-14 Reduced 0.51%	2,756 $946,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $21,543 - $25,102	67 Added 2.48%	2,770 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $5,929 - $6,757	20 Added 0.75%	2,703 $874,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $66,616 - $78,217	239 Added 9.78%	2,683 $870,000
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $22,295 - $27,707	-95 Reduced 3.74%	2,444 $700,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $50,591 - $62,784	225 Added 9.72%	2,539 $701,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $145,148 - $178,625	-655 Reduced 22.06%	2,314 $535,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $6,319 - $8,173	35 Added 1.19%	2,969 $681,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $670,096 - $867,472	-4,078 Reduced 58.16%	2,934 $548,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $132,938 - $175,909	1,019 Added 17.0%	7,012 $1.18 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $19,301 - $22,325	-132 Reduced 2.16%	5,993 $887,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $38,197 - $45,970	280 Added 4.79%	6,125 $1.01 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $8,571 - $10,609	72 Added 1.25%	5,845 $811,000
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $16,144 - $19,996	151 Added 2.69%	5,773 $759,000
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $6,514 - $7,085	61 Added 1.1%	5,622 $629,000
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $79,990 - $93,369	722 Added 14.92%	5,561 $616,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $1,558 - $1,834	14 Added 0.29%	4,839 $628,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $2,876 - $3,301	-38 Reduced 0.78%	4,825 $412,000
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $2,130 - $2,285	26 Added 0.54%	4,863 $411,000
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $372,787 - $413,756	4,837	4,837 $414,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.

Account

Bsw Wealth Partners Eli Lilly & CO Transaction History